Fund details
Takeda’s venture arm supports digital health innovations aimed at enhancing patient outcomes and healthcare delivery.
Go to profile
Partners related to this fund
No partner found.
Funds with similar target sectors
View all funds
Christophe Weber
President
Christophe Weber serves as President, CEO, and Representative Director of Takeda Pharmaceutical Company. He joined Takeda in 2014 as Chief Operating Officer and quickly rose to President and CEO by 2015. Weber has driven Takeda's globalization, instilling a unified "One Takeda" culture, transforming R&D, and enhancing corporate governance and ethics. Under his leadership, Takeda emerged as a leading global biopharmaceutical company. Previously, Weber worked at GlaxoSmithKline for 20 years in senior roles across Europe, Asia, and the U.S.
Investor scope
Investment criteria breakdown.
Investment stages
Pre-Seed
Seed
Series A
Series B+
Target regions
Asia-Pacific
USA
Europe
Investment ranges
$500K - $1M
$1M - $3M
$3M - $10M
Focus areas
Health
Biotech
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.
Related Sector Funds
Funds investing in similar sectors.
.svg)
